AUCKLAND, NZ – Biomatters is proud to announce the release of Geneious Prime 2019 today with a variety of features including significantly enhanced capability for primer design, an essential part of cloning operations in commercial organizations. New primer design functionality includes more interactive display options, simplified testing and annotation, and many useability tweaks aimed at […]
Quality certification means that the management system meets the requirements imposed by International Standard ISO 9001:2015. The certification covers product development, production and sales. By designing a quality management system with a strong customer focus in which all processes and procedures are meticulously formulated and quality-tested in compliance with the international standard, Genovis ensures that it […]
CAMBRIDGE, Mass – Ultivue, a life science company developing reagent-driven strategies for high-performance biological imaging in situ, today announced expanded capabilities of its proprietary InSituPlex® DNA-barcoding and staining technology. InSituPlex® now supports a higher level of multiplexed detection and quantification of markers in tissue samples while retaining all the benefits of the company’s UltiMapper™ assays. […]
Launching Test Bed for up to 10-plex assays with Simoa Sensitivity and Specificity to Advance Cancer Research LEXINGTON, Mass.– Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced an Early Access Program for the latest advance in Simoa Sensitivity assays for oncology. The Early Access test bed […]
Expedeon’s proprietary immunoassay technology to be incorporated into Quanterix’ Simoa Planar Immunoassay products Heidelberg, Germany and Cambridge, UK – Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard) today announced a supply and license agreement with United States based Life Sciences company, Quanterix Corporation. The agreement provides Quanterix access to Expedeon’s breadth of immunoassay technologies for application […]
MANASSAS, Va. — Reinforcing its long-established reputation for quality and reliability as the steward for credible biomaterial and standards in the biological sciences, ATCC today announced details of its new initiative, Incredible 2020. Building on ATCC’s non-profit mission, this Incredible 2020 initiative, which was unveiled at the Society for Neuroscience (SfN) 2018 annual conference in San Diego, CA, […]
Today, Bioinformatics Solutions Inc. (BSI) will be releasing PEAKS X within its PEAKS Studio platform, to provide a complete and vendor neutral solution for DDA and DIA discovery proteomics. The latest features added to the software include: • Resolution for Chimeric Spectra • Spectral-Library-Free DIA Support • De Novo Sequencing for DIA Data • Improved […]
Los Angeles, CA – Calibre Scientific is pleased to announce that it has completed the acquisition of Kalon Biological Limited and Clin-Tech Limited (together “KalonBio“ or the “Company”). The Company specializes in the development and manufacture of a range of medical diagnostic kits, commercial ELISA (enzyme immunoassays [EIA]) kits and reagents for the healthcare and […]
Translational Research Initiative Will Use PanCancer IO 360 Panel to Identify Predictive Signatures for MGD013 SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that MacroGenics(NASDAQ:MGNX) and NanoString have entered into a translational research agreement to identify and develop biomarkers for MacroGenics’ MGD013 program. MGD013 is an IgG4κ bispecific […]
Melbourne, Australia and Cambridge, Massachusetts – October 25, 2018 | Leica Biosystems and Ultivue begin Co-Marketing of UltiMapper™ Assay on the BOND RX enabling single-step automated multiplexing in under 6 hours. Building on its legacy of partnering with emerging technology leaders, Leica Biosystems have partnered with Ultivue and announced the co-marketing of Ultivue’s UltiMapper™ assays […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
